44976 Federal Register / Vol. 62, No. 164 / Monday, August 25, 1997 / Notices

advances will continue in the area of

allergenic extracts and that this

document may become outdated as

those advances occur. This draft

guidance document represents the

agency’s current thinking on testing

limits in stability protocols for

standardized grass pollen extracts. It

does not create or confer any rights for

or on any person and does not operate

to bind FDA or the public. An

alternative approach may be used if

such approach satisfies the

requirements of the applicable statute,

regulations, or both.

Interested persons may submit written

comments on the draft guidance

document to the Dockets Management

Branch (address above). Two copies of

any comments are to be submitted,

except that individuals may submit one.

Requests and comments should be

identified with the docket number

found in brackets in the heading of this

document. The draft guidance

document and received comments are

available for public examination in the

office above between 9 a.m. and 4 p.m.,

Monday through Friday. Comments

received will be considered in

determining whether further revision of

the draft guidance document is

warranted.

Persons with access to the INTERNET

may obtain the draft guidance document

by using the World Wide Web (WWW).

For WWW access, connect to CBER at

‘‘http://www.fda.gov/cber/

guidelines.htm’’.

Dated: August 15, 1997.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 97–22421 Filed 8–22–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Notice of Listing of Members of the

Food and Drug Administration’s Senior

Executive Service Performance Review

Board

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) announces the

persons who will serve on the FDA

Performance Review Board (PRB). This

action is being taken in accordance with

Title 5 U.S.C. 4314(c)(4), which requires

that members of performance review

boards be appointed in a manner to

ensure consistency, stability, and

objectivity in performance appraisals,

and requires that notice of the

appointment of an individual to serve as

a member be published in the Federal

Register.

FOR FURTHER INFORMATION CONTACT:

Arlene S. Karr, Office of Human

Resources and Management Services

(HFA–408), Food and Drug

Administration, 5600 Fishers Lane, rm.

7B–32, Rockville, MD 20857, 301–827–

4183.

The following persons will serve on the

FDA PRB, which oversees the

evaluation of performance appraisals of

FDA’s Senior Executive Service (SES)

members:

Michael A. Friedman, M.D.,

Chairperson

Robert J. Byrd

Margaret J. Porter

Sharon Smith Holston

Mary K. Pendergast

William B. Schultz

Dated: August 14, 1997.

Michael A. Friedman,

Lead Deputy Commissioner for the Food and

Drug Administration.

[FR Doc. 97–22420 Filed 8–22–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA 1763, 2088 and

R–142]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summaries of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

1. Type of Information Collection

Request: Reinstatement, without change,

of a previously approved collection for

which approval has expired; Title of

Information Collection: Request for

Termination of Premium Hospital and/

or Supplementary Medical Insurance

and Supporting Regulations in 42 CFR

406.28 and 407.27; Form No.: HCFA–

1763 (OMB No. 0938–0025); Use: The

HCFA–1763 is used by beneficiaries to

request voluntary termination from

premium hospital and/or

supplementary medical insurance.

Frequency: One time only; Affected

Public: Individuals or Households and

Federal Government; Number of

Respondents: 14,000; Total Annual

Responses: 14,000; Total Annual Hours:

5,833.

2. Type of Information Collection

Request: Extension of a currently

approved collection; Title of

Information Collection: Outpatient

Rehabilitation Cost Report and

Supporting Regulations in 42 CFR

413.20 and 413.24 Form No.: HCFA–

2088 (OMB No. 0938–0037); Use: This

form is used by Outpatient

Rehabilitation Facilities to report their

health care costs to determine the

amount reimbursable for services

furnished to Medicare beneficiaries.

Frequency: Annually; Affected Public:

Business or other for-profit, Not-forprofit institutions, and State, Local or

Tribal Government; Number of

Respondents: 4,298; Total Annual

Responses: 4,298; Total Annual Hours:

429,800.

3. Type of Information Collection

Request: Extension of a currently

approved collection; Title of

Information Collection: Information

Collection Requirements Contained in

BPD–393, Examination and Treatment

for Emergency Medical Conditions and

Women in Labor and Supporting

Regulations Contained in 42 CFR

488.18, 489.20 and 489.24; Document

No.: HCFA–-R–142 (OMB# 0938–0667);

Use: The Information Collection

Requirements contained in BPD–393,

Examination and Treatment for

Emergency Medical Conditions and

Women in Labor contains requirements

for hospitals to prevent them from

inappropriately transferring individuals

with emergency medical conditions, as

mandated by Congress. HCFA will use

this information to help assure

compliance with this mandate and

protect the public. This information is

not contained elsewhere in regulations.

Frequency: On occasion; Affected

Public: Individuals or Households, Notfor-profit institutions, Federal